TY - JOUR
T1 - The European Cancer Patient's Bill of Rights, update and implementation 2016
AU - Lawler, Mark
AU - Banks, Ian
AU - Law, Kate
AU - Albreht, Tit
AU - Armand, Jean Pierre
AU - Barbacid, Mariano
AU - Barzach, Michèle
AU - Bergh, Jonas
AU - Cameron, David
AU - Conte, Pierfranco
AU - De Braud, Filippo
AU - De Gramont, Aimery
AU - De Lorenzo, Francesco
AU - Diehl, Volker
AU - Diler, Sarper
AU - Erdem, Sema
AU - Geissler, Jan
AU - Gore-Booth, Jola
AU - Henning, Geoffrey
AU - Højgaard, Liselotte
AU - Horgan, Denis
AU - Jassem, Jacek
AU - Johnson, Peter
AU - Kaasa, Stein
AU - Kapitein, Peter
AU - Karjalainen, Sakari
AU - Kelly, Joan
AU - Kienesberger, Anita
AU - La Vecchia, Carlo
AU - Lacombe, Denis
AU - Lindahl, Tomas
AU - Löwenberg, Bob
AU - Luzzatto, Lucio
AU - Malby, Rebecca
AU - Mastris, Ken
AU - Meunier, Françoise
AU - Murphy, Martin
AU - Naredi, Peter
AU - Nurse, Paul
AU - Oliver, Kathy
AU - Pearce, Jonathan
AU - Pelouchov, Jana
AU - Piccart, Martine
AU - Pinedo, Bob
AU - Spurrier-Bernard, Gilly
AU - Sullivan, Richard
AU - Tabernero, Josep
AU - Van De Velde, Cornelis
AU - Van Herk, Bert
AU - Johnston, Patrick
AU - European Cancer Concord (ECC)
PY - 2016/12/1
Y1 - 2016/12/1
N2 - In this implementation phase of the European Cancer Patient's Bill of Rights (BoR), we confirm the following three patient-centred principles that underpin this initiative: The right of every European citizen to receive the most accurate information and to be proactively involved in his/her care. The right of every European citizen to optimal and timely access to a diagnosis and to appropriate specialised care, underpinned by research and innovation. The right of every European citizen to receive care in health systems that ensure the best possible cancer prevention, the earliest possible diagnosis of their cancer, improved outcomes, patient rehabilitation, best quality of life and affordable health care. The key aspects of working towards implementing the BoR are: Agree our high-level goal. The vision of 70% long-term survival for patients with cancer in 2035, promoting cancer prevention and cancer control and the associated progress in ensuring good patient experience and quality of life. Establish the major mechanisms to underpin its delivery. (1) The systematic and rigorous sharing of best practice between and across European cancer healthcare systems and (2) the active promotion of Research and Innovation focused on improving outcomes; (3) Improving access to new and established cancer care by sharing best practice in the development, approval, procurement and reimbursement of cancer diagnostic tests and treatments. Work with other organisations to bring into being a Europe based centre that will (1) systematically identify, evaluate and validate and disseminate best practice in cancer management for the different countries and regions and (2) promote Research and Innovation and its translation to maximise its impact to improve outcomes.
AB - In this implementation phase of the European Cancer Patient's Bill of Rights (BoR), we confirm the following three patient-centred principles that underpin this initiative: The right of every European citizen to receive the most accurate information and to be proactively involved in his/her care. The right of every European citizen to optimal and timely access to a diagnosis and to appropriate specialised care, underpinned by research and innovation. The right of every European citizen to receive care in health systems that ensure the best possible cancer prevention, the earliest possible diagnosis of their cancer, improved outcomes, patient rehabilitation, best quality of life and affordable health care. The key aspects of working towards implementing the BoR are: Agree our high-level goal. The vision of 70% long-term survival for patients with cancer in 2035, promoting cancer prevention and cancer control and the associated progress in ensuring good patient experience and quality of life. Establish the major mechanisms to underpin its delivery. (1) The systematic and rigorous sharing of best practice between and across European cancer healthcare systems and (2) the active promotion of Research and Innovation focused on improving outcomes; (3) Improving access to new and established cancer care by sharing best practice in the development, approval, procurement and reimbursement of cancer diagnostic tests and treatments. Work with other organisations to bring into being a Europe based centre that will (1) systematically identify, evaluate and validate and disseminate best practice in cancer management for the different countries and regions and (2) promote Research and Innovation and its translation to maximise its impact to improve outcomes.
KW - Bill of Rights
KW - Cancer Concord
KW - Cancer outcomes
U2 - 10.1136/esmoopen-2016-000127
DO - 10.1136/esmoopen-2016-000127
M3 - Review article
AN - SCOPUS:85044632674
SN - 2059-7029
VL - 1
JO - ESMO Open
JF - ESMO Open
IS - 6
M1 - e000127
ER -